Profile of hemotherapy care and the safety of the transfusion process

Rev Assoc Med Bras (1992). 2022 Jun 24;68(6):770-774. doi: 10.1590/1806-9282.20211246. eCollection 2022.

Abstract

Objective: This study aimed to evaluate the safety of the transfusion process in a public teaching hospital and to outline the profile of the hemotherapy care provided.

Methods: This was an exploratory, descriptive, and prospective study with a quantitative approach and grounded in field research. Data were obtained from medical and nursing records and active search.

Results: Concentrated red blood cells were the most transfused blood component. Inadequate indications of blood components were detected in 15% of Concentrated red blood cells transfusions, 20% of fresh plasma, 29.2% of platelet concentrates, and 36.4% of cryoprecipitates. Filling out the blood component request forms, the nursing checklist and the entry book were inadequate in 88.3, 92.8, and 69.5% of the procedures, respectively.

Conclusions: Faults were identified throughout the transfusion process, revealing inadequate compliance with current standards and legislation, essential in minimizing the occurrence of errors and maximizing the safety of transfusion. Studies of this nature reinforce the need for continued research in this field.

MeSH terms

  • Blood Component Transfusion*
  • Blood Transfusion*
  • Erythrocyte Transfusion
  • Erythrocytes
  • Humans
  • Prospective Studies